{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T12:53:27Z","timestamp":1782824007484,"version":"3.54.5"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["20AA2005"],"award-info":[{"award-number":["20AA2005"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jns.2023.120774","type":"journal-article","created":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T11:13:46Z","timestamp":1692962026000},"page":"120774","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Epidemiology of progressive multifocal leukoencephalopathy in Japan and effectiveness of mefloquine: A retrospective analysis of a nationwide inpatient database"],"prefix":"10.1016","volume":"453","author":[{"given":"Hiromichi","family":"Otaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinobu","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyohide","family":"Fushimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2023.120774_bb0005","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S1474-4422(18)30040-1","article-title":"Pathogenesis of progressive multifocal leukoencephalopathy and risks associated with treatments for multiple sclerosis: a decade of lessons learned","volume":"17","author":"Major","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2023.120774_bb0010","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41582-020-00427-y","article-title":"Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease","volume":"17","author":"Cortese","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jns.2023.120774_bb0015","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/ana.24371","article-title":"Persistence and pathogenesis of the neurotropic polyomavirus JC","volume":"77","author":"Wollebo","year":"2015","journal-title":"Ann. Neurol."},{"issue":"Suppl. 2","key":"10.1016\/j.jns.2023.120774_bb0020","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.3949\/ccjm.78.s2.03","article-title":"The clinical features of PML","volume":"78","author":"Berger","year":"2011","journal-title":"Cleve. Clin. J. Med."},{"key":"10.1016\/j.jns.2023.120774_bb0025","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1212\/WNL.0b013e31828c2fa1","article-title":"PML diagnostic criteria: consensus statement from the AAN Neuroinfectious disease section","volume":"80","author":"Berger","year":"2013","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2023.120774_bb0030","first-page":"93","article-title":"Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease","volume":"81","author":"Astrom","year":"1958","journal-title":"Brain."},{"key":"10.1016\/j.jns.2023.120774_bb0035","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0733-8619(18)31105-8","article-title":"Progressive multifocal leukoencephalopathy","volume":"2","author":"Brooks","year":"1984","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.jns.2023.120774_bb0040","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJM198212023072307","article-title":"Progressive multifocal leukoencephalopathy in a male homosexual with T-cell immune deficiency","volume":"307","author":"Miller","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2023.120774_bb0045","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1007\/s12028-022-01455-w","article-title":"It was 40 years ago today: AIDS and the brain","volume":"36","author":"Wijdicks","year":"2022","journal-title":"Neurocrit. Care."},{"key":"10.1016\/j.jns.2023.120774_bb0050","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/ana.10827","article-title":"Changing incidence of central nervous system diseases in the EuroSIDA cohort","volume":"55","author":"d\u2019Arminio Monforte","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2023.120774_bb0055","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1086\/598335","article-title":"Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV cohort study","volume":"48","author":"Khanna","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jns.2023.120774_bb0060","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1086\/595299","article-title":"Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study","volume":"199","author":"Engsig","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jns.2023.120774_bb0065","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/cid\/ciy074","article-title":"Risk of progressive multifocal leukoencephalopathy in the combination antiretroviral therapy era in the French hospital database on human immunodeficiency virus (ANRS-C4)","volume":"67","author":"Melliez","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jns.2023.120774_bb0070","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/cen3.12440","article-title":"Drug-induced progressive multifocal leukoencephalopathy in multiple sclerosis: a comprehensive review","volume":"9","author":"Yukitake","year":"2018","journal-title":"Clinical and Experimental Neuroimmunology."},{"key":"10.1016\/j.jns.2023.120774_bb0075","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000618","article-title":"Progressive multifocal leukoencephalopathy: a 25-year retrospective cohort study","volume":"6","author":"Anand","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"10.1016\/j.jns.2023.120774_bb0080","doi-asserted-by":"crossref","first-page":"e498","DOI":"10.1212\/WNL.0000000000004926","article-title":"The national incidence of PML in Sweden, 1988-2013","volume":"90","author":"Iacobaeus","year":"2018","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2023.120774_bb0085","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/brain\/awac237","article-title":"Progressive multifocal leukoencephalopathy: epidemiology and spectrum of predisposing conditions","volume":"146","author":"Joly","year":"2022","journal-title":"Brain."},{"key":"10.1016\/j.jns.2023.120774_bb0090","first-page":"ofz024","article-title":"The incidence and predisposing factors of John Cunningham virus-induced progressive multifocal leukoencephalopathy in southern Finland: a population-based study, open forum","volume":"6","author":"Kartau","year":"2019","journal-title":"Infect Dis."},{"key":"10.1016\/j.jns.2023.120774_bb0095","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00415-018-09167-y","article-title":"Progressive multifocal leukoencephalopathy in Finland: a cross-sectional registry study","volume":"266","author":"Sipila","year":"2019","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2023.120774_bb0100","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1159\/000526132","article-title":"Progressive multifocal leukoencephalopathy in relapsed Ph+ acute lymphoblastic leukemia after cord blood transplantation and Blinatumomab treatment: a case report and literature review","volume":"145","author":"Edahiro","year":"2022","journal-title":"Acta Haematol."},{"key":"10.1016\/j.jns.2023.120774_bb0105","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00415-019-09629-x","article-title":"Successful treatment of non-HIV progressive multifocal leukoencephalopathy: case report and literature review","volume":"267","author":"Hamaguchi","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2023.120774_bb0110","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s12883-019-1493-1","article-title":"Probable progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with immunosuppressant dose reduction following lung transplantation: a case report and literature review","volume":"19","author":"Ishii","year":"2019","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jns.2023.120774_bb0115","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jns.2014.03.048","article-title":"Favorable outcome after withdrawal of immunosuppressant therapy in progressive multifocal leukoencephalopathy after renal transplantation: case report and literature review","volume":"341","author":"Ohara","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2023.120774_bb0120","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12883-018-1041-4","article-title":"Progressive multifocal leukoencephalopathy associated with thymoma with immunodeficiency: a case report and literature review","volume":"18","author":"Ueno","year":"2018","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jns.2023.120774_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/v15040968","article-title":"Nationwide Laboratory surveillance of progressive multifocal leukoencephalopathy in Japan: fiscal years 2011-2020","volume":"15","author":"Nakamichi","year":"2023","journal-title":"Viruses."},{"key":"10.1016\/j.jns.2023.120774_bb0130","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1471-2377-12-121","article-title":"Characteristics of progressive multifocal leukoencephalopathy clarified through internet-assisted laboratory surveillance in Japan","volume":"12","author":"Nakamichi","year":"2012","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jns.2023.120774_bb0135","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/00002030-199810000-00006","article-title":"Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy","volume":"12","author":"Albrecht","year":"1998","journal-title":"AIDS."},{"key":"10.1016\/j.jns.2023.120774_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020967","article-title":"Improved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapy","volume":"6","author":"Gasnault","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2023.120774_bb0145","first-page":"421","article-title":"Prolonged survival without neurological improvement in patients with AIDS-related progressive multifocal leukoencephalopathy on potent combined antiretroviral therapy","volume":"5","author":"Gasnault","year":"1999","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jns.2023.120774_bb0150","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1128\/AAC.01614-08","article-title":"Identification and characterization of mefloquine efficacy against JC virus in vitro","volume":"53","author":"Brickelmaier","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jns.2023.120774_bb0155","first-page":"351","article-title":"A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes","volume":"19","author":"Clifford","year":"2013","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jns.2023.120774_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2188\/jea.JE20200288","article-title":"History and profile of diagnosis procedure combination (DPC): development of a real data collection system for acute inpatient Care in Japan","volume":"31","author":"Hayashida","year":"2021","journal-title":"J Epidemiol."},{"key":"10.1016\/j.jns.2023.120774_bb0165","first-page":"19","article-title":"Clinical epidemiology and health services research using the diagnosis procedure combination database in Japan, Asian Pacific journal of","volume":"7","author":"Yasunaga","year":"2015","journal-title":"Dis. Manag."},{"key":"10.1016\/j.jns.2023.120774_bb0170","article-title":"Development and validation of a novel method for converting the Japan Coma Scale to Glasgow Coma Scale","author":"Nakajima","year":"2022","journal-title":"J Epidemiol."},{"key":"10.1016\/j.jns.2023.120774_bb0175","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries","volume":"173","author":"Quan","year":"2011","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.jns.2023.120774_bb0180","series-title":"Research Group for Therapy of HIV Infection","author":"Treatment guideline for HIV (in Japanese)","year":"2023"},{"key":"10.1016\/j.jns.2023.120774_bb0185","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12984-022-01075-7","article-title":"Cross-validation of predictive models for functional recovery after post-stroke rehabilitation","volume":"19","author":"Campagnini","year":"2022","journal-title":"J Neuroeng Rehabil."},{"key":"10.1016\/j.jns.2023.120774_bb0190","author":"Yamada"},{"key":"10.1016\/j.jns.2023.120774_bb0195","first-page":"1","article-title":"Mice: multivariate imputation by chained equations in R","volume":"45","author":"van Buuren","year":"2011","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.jns.2023.120774_bb0200","doi-asserted-by":"crossref","first-page":"292","DOI":"10.32614\/RJ-2021-073","article-title":"MatchThem: matching and weighting after multiple imputation","volume":"13","author":"Pishgar","year":"2021","journal-title":"The R Journal."},{"key":"10.1016\/j.jns.2023.120774_bb0205","author":"OECD"},{"key":"10.1016\/j.jns.2023.120774_bb0210","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/cen3.12411","article-title":"Prevalence, treatments and medical cost of multiple sclerosis in Japan based on analysis of a health insurance claims database","volume":"8","author":"Ogino","year":"2017","journal-title":"Clin Exp Neuroimmunol."},{"key":"10.1016\/j.jns.2023.120774_bb0215","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: insights from the atlas of MS","volume":"26","author":"Walton","year":"2020","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2023.120774_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0256452","article-title":"Nationwide surveillance of AIDS-defining illnesses among HIV patients in Japan from 1995 to 2017","volume":"16","author":"Tanaka","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2023.120774_bb0225","author":"Yamada"},{"key":"10.1016\/j.jns.2023.120774_bb0230","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.2169\/internalmedicine.51.6810","article-title":"Mefloquine improved progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus","volume":"51","author":"Beppu","year":"2012","journal-title":"Intern. Med."},{"key":"10.1016\/j.jns.2023.120774_bb0235","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/jnnp.2009.190652","article-title":"Mefloquine in the treatment of progressive multifocal leukoencephalopathy","volume":"82","author":"Gofton","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2023.120774_bb0240","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.jocn.2013.12.031","article-title":"Mefloquine improved progressive multifocal leukoencephalopathy in a patient with immunoglobulin a nephropathy","volume":"21","author":"Shin","year":"2014","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.jns.2023.120774_bb0245","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1007\/s00415-016-8217-x","article-title":"Drug-associated progressive multifocal leukoencephalopathy: a clinical, radiological, and cerebrospinal fluid analysis of 326 cases","volume":"263","author":"Maas","year":"2016","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2023.120774_bb0250","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.je.2016.09.009","article-title":"Validity of diagnoses, procedures, and laboratory data in Japanese administrative data","volume":"27","author":"Yamana","year":"2017","journal-title":"J Epidemiol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X23002356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X23002356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T16:02:13Z","timestamp":1758384133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X23002356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":50,"alternative-id":["S0022510X23002356"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2023.120774","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology of progressive multifocal leukoencephalopathy in Japan and effectiveness of mefloquine: A retrospective analysis of a nationwide inpatient database","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2023.120774","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120774"}}